首页 > 文献资料库 > 详情

Injection technique in neurotoxins and fillers: Indications, products, and outcomes

Murad Alam, MD, MBA, MSCI, and Rebecca Tung, MD Chicago and Maywood, Illinois


你可能喜欢...

08-12

2021

Safety of poly-L-lactic acid (New-Fill®) in the treatment of facial lipoatrophy: a large observation

This study demonstrated, in real-life conditions and on a large sample, that PLLA injections were feasible, efficient, and safe when performed by trained physicians.

09-22

2021

Advanced injection techniques of poly-L-lactic acid: a case-based presentation

This article presents a patient who illustrates the current treatment techniques that optimize the efficacy and tolerability of poly-L-lactic acid.

09-22

2021

Consensus Recommendations on the Use of Injectable Poly-L-Lactic Acid for Facial and Nonfacial Volum

Poly-L-lactic acid (PLLA) was approved for use in Europe in 1999. In the United States, it was approved by the Food and Drug Administration in 2004 for the treatment of facial lipoatrophy associated with human immunodeficiency virus, and in 2009 for cosm